HistoSonics Revenue and Competitors
Estimated Revenue & Valuation
- HistoSonics's estimated annual revenue is currently $56.8M per year.
- HistoSonics's estimated revenue per employee is $313,750
- HistoSonics's total funding is $214M.
Employee Data
- HistoSonics has 181 Employees.
- HistoSonics grew their employee count by 50% last year.
HistoSonics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | VP Sales | Reveal Email/Phone |
3 | VP Reimbursement | Reveal Email/Phone |
4 | VP Regulatory Affairs | Reveal Email/Phone |
5 | VP Marketing | Reveal Email/Phone |
6 | VP Clinical Affairs | Reveal Email/Phone |
7 | VP R&D | Reveal Email/Phone |
8 | VP Operations | Reveal Email/Phone |
9 | Area Sales Director | Reveal Email/Phone |
10 | Director Operations Finance | Reveal Email/Phone |
HistoSonics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $33.6M | 134 | 10% | N/A | N/A |
#2 | $13.8M | 55 | -8% | N/A | N/A |
#3 | $21.3M | 85 | 8% | N/A | N/A |
#4 | $6.8M | 27 | 13% | N/A | N/A |
#5 | $75M | 289 | 1% | N/A | N/A |
#6 | $11.5M | 46 | -6% | N/A | N/A |
#7 | $20.3M | 81 | -16% | N/A | N/A |
#8 | $1.3M | 5 | 25% | N/A | N/A |
#9 | $20.6M | 82 | 8% | N/A | N/A |
#10 | $5.3M | 21 | -12% | N/A | N/A |
What Is HistoSonics?
HistoSonics is developing a non-invasive, autonomous robotic platform capable of destroying tissue at a sub-cellular level with a novel beam therapy and new medical procedure called Robotically Assisted Sonic Therapy (RAST)?. RAST is based on the science of histotripsy, a non-invasive, non-thermal and non-ionizing radiation modality developed at the University of Michigan that uses the pressure created by focused sound energy to completely ablate or destroy tissue at a sub-cellular level.
keywords:Biotechnology
$214M
Total Funding
181
Number of Employees
$56.8M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HistoSonics News
... of histotripsy in the fight against cancer, leading to the clinical trial #HOPE4LIVER sponsored by HistoSonics, a U-M spinoff company.
The human trial currently ongoing for histotripsy, called #HOPE4LIVER, is sponsored by HistoSonics, a company created by the University of Michigan.
MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ -- HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today the treatment of the first patient in the #HOPE4LIVER US Study. The investigational device study was approved by the FDA in the fourth quarter of 2020. The ...
MINNEAPOLIS, Jan. 11, 2021 /PRNewswire/ -- HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today that it has received approval to initiate the company's second European clinical trial of its new platform technology, which is designed to use the science ...
MINNEAPOLIS, Oct. 5, 2020 /PRNewswire/ -- HistoSonics, developer of a non-invasive platform and novel sonic beam therapy, announced today that it has received approval of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin a clinical trial of its ...
Other Companies in Ann Arbor
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $29M | 182 | 0% | N/A |
#2 | $46.4M | 186 | 33% | N/A |
#3 | $49.4M | 188 | 11% | N/A |
#4 | $57.6M | 194 | 9% | N/A |
#5 | $34.8M | 198 | 6% | N/A |